The FDA expanded its emergency use authorizations for Moderna’s and Pfizer’s omicron-focused boosters Dec. 8 to include children as young as 6 months old.
Read the full post on Becker's Hospital Review - Healthcare News
FDA authorizes tweaked boosters for young children
